Back to Search
DAVID CAMIDGE, MD
MD
Medical Oncology Physician
NPI: 1336239912IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
46519(CO)
Education
OTHER
Class of 1995
Research & Publications (20)
Apomab: an agonist monoclonal antibody directed against Death Receptor 5/TRAIL-Receptor 2 for use in the treatment of solid tumors.
PMID 18613768·Expert Opin Biol Ther·2008
7-preclinical
A phase I safety, tolerability, and pharmacokinetic study of enzastaurin combined with capecitabine in patients with advanced solid tumors.
PMID 18043132·Anticancer Drugs·2008
3-trial
The potential of death receptor 4- and 5-directed therapies in the treatment of lung cancer.
PMID 17681093·Clin Lung Cancer·2007
6-review
The rationale and development of therapeutic insulin-like growth factor axis inhibition for lung and other cancers.
PMID 19632946·Clin Lung Cancer·2009
6-review
The impact of prognosis without treatment on doctors' and patients' resource allocation decisions and its relevance to new drug recommendation processes.
PMID 18251760·Br J Clin Pharmacol·2008
4-observational
Hospital admissions and deaths relating to deliberate self-harm and accidents within 5 years of a cancer diagnosis: a national study in Scotland, UK.
PMID 17299389·Br J Cancer·2007
8-other
Factors affecting the mesothelioma detection rate within national and international epidemiological studies: insights from Scottish linked cancer registry-mortality data.
PMID 16909142·Br J Cancer·2006
8-other
Brachial plexopathy affecting the development of Beau's lines unilaterally.
PMID 11905750·Lancet Oncol·2001
5-case
Cutaneous B cell lymphoma arising from a chronically inflamed sebaceous cyst.
PMID 11905683·Lancet Oncol·2000
5-case
Mapatumumab, an antibody targeting TRAIL-R1, in combination with paclitaxel and carboplatin in patients with advanced solid malignancies: results of a phase I and pharmacokinetic study.
PMID 19652058·J Clin Oncol·2009
3-trial
Surprised by stage III: unexpected N2 lymph node involvement found during surgery for early-stage NSCLC.
PMID 19476276·Oncology (Williston Park)·2009
5-case
Is there a role for consolidative stereotactic body radiation therapy following first-line systemic therapy for metastatic lung cancer? A patterns-of-failure analysis.
PMID 19373699·Acta Oncol·2009
8-other
Economic evaluation of fulvestrant as an extra step in the treatment sequence for ER-positive advanced breast cancer.
PMID 19018261·Br J Cancer·2008
8-other
Bronchioloalveolar carcinoma presenting as chronic progressive pulmonary infiltrates in a woman with HIV: a diagnosis worth making.
PMID 18978572·J Thorac Oncol·2008
5-case
Summary report 7th Annual Targeted Therapies of the Treatment of Lung Cancer.
PMID 18449013·J Thorac Oncol·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 12605 E 16TH AVE
AURORA, CO 80045 - Phone
- (720) 848-0000
Quick Facts
- NPI
- 1336239912
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 31
- Publications
- 20
Are you this provider?
Claim Your Profile